PPD Opens Vaccine Clinical Research Center in Taizhou, China (Business Wire)
WILMINGTON, N.C.----PPD, Inc. today announced it has opened a vaccine clinical research center in Taizhou, China, further strengthening its clinical research and development services in one of the country’s major regions for conducting vaccine studies. us.rd.yahoo.com |
Psychiatric Group to Unveil Guidelines to Curb Conflicts
The American Psychiatric Association is set to unveil conflict-of-interest guidelines today for its members. online.wsj.com |
U.K. Approves Botox for Migraines
Allergan said the U.K.'s drug regulator became the first in the world to approve Botox as a tool for preventing chronic migraine headaches. online.wsj.com |
Cypress Risks Deepening Disquiet With Another Spending Spree
EP Vantage submits:One could be forgiven for thinking it rather provocative that a board under fire for an apparently misguided license deal should go straight out and strike two more. Perhaps a sign of single mindedness is exactly the message that Cypress Bioscience (CYPB) is trying to send to its activist hedgefund shareholder, Ramius.After Cypress’ share price halved in value to $2.16 in the wake of a licensing deal over BioLineRx’s antipsychotic CYP-1020 (BL-1020) in June, Ramius ramped up its vociferous calls for change and offered to buy the company for $4 per share, rather than see more money wasted (Ramius fires warning shot across Cypress’s bow, July 20, 2010). Rather than negotiate, Cypress has bought rights to two early-stage projects, Alexza Pharmaceuticals’ (ALXA) Staccato nicotine drug delivery platform, and autism drug carbetocin from Marina Biotech. Some analysts reckon these deals signal Cypress’ intention to press ahead unabated. The question for shareholders is whether this is a viable vision for the future.Complete Story » seekingalpha.com |
Experts to Find, Fight Epidemics
A U.S.-funded program is helping dozens of countries step up efforts to respond to disease threats as epidemics add to the burden on their health-care systems and new pathogens spread around the globe. online.wsj.com |